Henlez Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Investors
-
3
Henlez General Information
Description
Developer of a biotechnology platform designed to support dermatology drug development through topical enzyme-based therapies. The company offers a proprietary topical GEP enzyme technology platform for dermatological applications, enabling pharmaceutical companies and healthcare providers to develop targeted skin treatment products and advance dermatology innovation.
Contact Information
Website
www.henlez.comCorporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Corporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Henlez Timeline
Henlez Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | Upcoming | Pre-Clinical Trials | ||||
| 5. Later Stage VC | 11-Dec-2024 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 23-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 24-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 25-Nov-2021 | $7.71K | $76.2K | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2020 | $68.5K | $68.5K | Completed | Startup |
Henlez Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Series 1 | 18,518 | $56.78 | $56.78 | 1x | $56.78 | 23.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Henlez Patents
Henlez Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021257618-A1 | Compositions and methods for treating hair follicle-linked conditions | Active | 15-Apr-2020 | ||
| AU-2021257618-B2 | Compositions and methods for treating hair follicle-linked conditions | Active | 15-Apr-2020 | ||
| CA-3180191-A1 | Compositions and methods for treating hair follicle-linked conditions | Pending | 15-Apr-2020 | ||
| EP-4135755-A1 | Compositions and methods for treating hair follicle-linked conditions | Active | 15-Apr-2020 | ||
| EP-4135755-B1 | Compositions and methods for treating hair follicle-linked conditions | Active | 15-Apr-2020 | A61K8/66 |
Henlez Signals
Henlez Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eir Ventures | Venture Capital | Minority | ||
| Nordic Mentor Network For Entrepreneurship | Accelerator/Incubator | |||
| InnoFounder | Accelerator/Incubator | Minority |
Henlez FAQs
-
When was Henlez founded?
Henlez was founded in 2019.
-
Where is Henlez headquartered?
Henlez is headquartered in Copenhagen, Denmark.
-
What is the size of Henlez?
Henlez has 1 total employees.
-
What industry is Henlez in?
Henlez’s primary industry is Biotechnology.
-
Is Henlez a private or public company?
Henlez is a Private company.
-
What is Henlez’s current revenue?
The current revenue for Henlez is .
-
How much funding has Henlez raised over time?
Henlez has raised $2.48M.
-
Who are Henlez’s investors?
Eir Ventures, Nordic Mentor Network For Entrepreneurship, and InnoFounder have invested in Henlez.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process